Badgley, Phelps & Bell’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$200K Hold
11,000
0.01% 215
2021
Q1
$248K Hold
11,000
0.01% 199
2020
Q4
$221K Hold
11,000
0.01% 201
2020
Q3
$269K Hold
11,000
0.01% 185
2020
Q2
$261K Hold
11,000
0.01% 174
2020
Q1
$189K Hold
11,000
0.01% 174
2019
Q4
$194K Hold
11,000
0.01% 191
2019
Q3
$195K Hold
11,000
0.01% 189
2019
Q2
$235K Hold
11,000
0.01% 182
2019
Q1
$262K Hold
11,000
0.02% 178
2018
Q4
$216K Sell
11,000
-250
-2% -$4.46K 0.02% 178
2018
Q3
$199K Hold
11,250
0.01% 184
2018
Q2
$242K Hold
11,250
0.02% 170
2018
Q1
$249K Hold
11,250
0.02% 170
2017
Q4
$342K Buy
+11,250
New +$299K 0.02% 159

Other funds holding EXEL

Badgley, Phelps & Bell's EXEL Position: Q2 2021 in Review

Badgley, Phelps & Bell held its Exelixis (EXEL) position steady in Q2 2021 at 11,000 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #215.

Badgley, Phelps & Bell first reported a position in EXEL in Q4 2017 and has held it in 15 quarters since. The position peaked at $342K in Q4 2017. 344 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

  • Badgley, Phelps & Bell held 11,000 shares of Exelixis worth $200K as of Q2 2021.
  • Badgley, Phelps & Bell left its Exelixis share count unchanged in Q2 2021.
  • Exelixis made up 0.01% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #215 holding.
  • Badgley, Phelps & Bell first reported a position in Exelixis in Q4 2017 and has held it in 15 quarters since.
  • Badgley, Phelps & Bell's Exelixis position peaked at $342K in Q4 2017.
  • 344 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.